Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Testa

Showing results (281-290 of 395) with videos related to

Pageof 40
Sort By:
Oncology Reports|May 20, 2011
Second line chemotherapy for metastatic colorectal carcinomaV Gebbia, A Testa, G Cannata, et al.
Anticancer Research|September 3, 1999
Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusionV Gebbia, G Mauceri, A Testa, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomachV Gebbia, A Testa, R Valenza, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|September 1, 1994
Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neckV Gebbia, R Valenza, A Testa, et al.
British Journal of Cancer|November 1, 1995
Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM)G Colucci, S Romito, V Gebbia, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1992
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with glutathione protection in patients with advanced head and neck cancerV Gebbia, R Valenza, A Testa, et al.
The New England Journal of Medicine|March 17, 1994
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials GroupW R Lenderking, R D Gelber, D J Cotton, et al.
European Journal of Nuclear Medicine|January 1, 1990
Thyroid carcinoma mimicking a toxic adenomaG De Rosa, A Testa, M Maurizi, et al.
Techniques in Coloproctology|June 23, 2026
Evaluation of the efficacy of a Propionibacterium extract gel in wound healing and symptom relief after open excisional hemorrhoidectomy: a randomized clinical studyS Deidda, C Eberspacher, V Argiolas, et al.
Annals of Internal Medicine|June 15, 1992
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials GroupR D Gelber, W R Lenderking, D J Cotton, et al.
Pageof 40

Showing results (281-290 of 395) with videos related to

Sort By:
Pageof 40
Oncology Reports|May 20, 2011
Second line chemotherapy for metastatic colorectal carcinomaV Gebbia, A Testa, G Cannata, et al.
Anticancer Research|September 3, 1999
Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusionV Gebbia, G Mauceri, A Testa, et al.
Journal of Chemotherapy (Florence, Italy)|April 1, 1994
Combination chemotherapy of 5-fluorouracil, epidoxorubicin and mitomycin C in the palliative treatment of locally advanced and/or metastatic adenocarcinoma of the stomachV Gebbia, A Testa, R Valenza, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|September 1, 1994
Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neckV Gebbia, R Valenza, A Testa, et al.
British Journal of Cancer|November 1, 1995
Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM)G Colucci, S Romito, V Gebbia, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1992
Weekly 5-fluorouracil and folinic acid plus escalating doses of cisplatin with glutathione protection in patients with advanced head and neck cancerV Gebbia, R Valenza, A Testa, et al.
The New England Journal of Medicine|March 17, 1994
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials GroupW R Lenderking, R D Gelber, D J Cotton, et al.
European Journal of Nuclear Medicine|January 1, 1990
Thyroid carcinoma mimicking a toxic adenomaG De Rosa, A Testa, M Maurizi, et al.
Techniques in Coloproctology|June 23, 2026
Evaluation of the efficacy of a Propionibacterium extract gel in wound healing and symptom relief after open excisional hemorrhoidectomy: a randomized clinical studyS Deidda, C Eberspacher, V Argiolas, et al.
Annals of Internal Medicine|June 15, 1992
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials GroupR D Gelber, W R Lenderking, D J Cotton, et al.
Pageof 40